Abstract
Case:
A 32-year-old man developed lumbar discitis and osteomyelitis after receiving a cell-based injection for the treatment of degenerative disc disease. Initial cultures were negative, but he continued to worsen, and a repeat set of cultures was taken. On day 10, Cutibacterium acnes was isolated. He was then successfully treated with 12 weeks of intravenous antibiotics.
Conclusions:
There is minimal regulation on the preparation or administration of cell-based interventions. It is important to consider slow growing organisms such as C. acnes in patients presenting with spinal infection with insidious onset after these treatments.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / administration & dosage
-
Daptomycin / administration & dosage
-
Discitis / diagnostic imaging*
-
Discitis / drug therapy
-
Discitis / microbiology
-
Humans
-
Intervertebral Disc Degeneration / therapy*
-
Intervertebral Disc Displacement / therapy*
-
Magnetic Resonance Imaging
-
Male
-
Osteomyelitis / diagnostic imaging*
-
Osteomyelitis / drug therapy
-
Osteomyelitis / microbiology
-
Propionibacteriaceae / isolation & purification
-
Radionuclide Imaging
-
Stem Cell Transplantation / adverse effects*
-
Technetium Tc 99m Exametazime
-
Transplantation, Autologous
Substances
-
Anti-Bacterial Agents
-
Technetium Tc 99m Exametazime
-
Daptomycin
Supplementary concepts
-
Cutibacterium acnes subsp. acnes
-
Intervertebral disc disease